Evidence map›Paper›PMID 28217194›Full record

ArticleThe open microbiology journal2016

Prevalence, Antibiogram and Molecular Characterization of Comunity-Acquired Methicillin-Resistant

Blessing Ike, Malachy C Ugwu, Moses N Ikegbunam, David Nwobodo, Chika Ejikeugwu, Thaddeus Gugu, Charles O Esimone

Open access · diamondAbstract read
In one paragraph

Article in The open microbiology journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Linezolid MIC creep among clinically significantFrontiers in antibiotics · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Blessing IkeDepartment of Pharmaceutical Microbiology and Biotechnology, Nnamdi Azikiwe University, Awka, Anambra Nigeria.
Malachy C UgwuDepartment of Pharmaceutical Microbiology and Biotechnology, Nnamdi Azikiwe University, Awka, Anambra Nigeria.
Moses N IkegbunamDepartment of Pharmaceutical Microbiology and Biotechnology, Nnamdi Azikiwe University, Awka, Anambra Nigeria.
David NwobodoDepartment of Pharmaceutical Microbiology and Biotechnology, Nnamdi Azikiwe University, Awka, Anambra Nigeria.
Chika EjikeugwuDepartment of Pharmaceutical Microbiology and Biotechnology, Nnamdi Azikiwe University, Awka, Anambra Nigeria.
Thaddeus GuguDepartment of Pharmaceutical Microbiology and Biotechnology, Nnamdi Azikiwe University, Awka, Anambra Nigeria.
Charles O EsimoneDepartment of Pharmaceutical Microbiology and Biotechnology, Nnamdi Azikiwe University, Awka, Anambra Nigeria.
Nnamdi Azikiwe University · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study evaluated the prevalence, antibiogram and molecular features of CA-MRSA in Awka, Nigeria.

methodsConfirmation of MRSA was done by testing resistance to oxacillin (1µg), cloxacillin (5µg) and cefoxitin

resultThe overall prevalence of MRSA was 22.6%. The carriage rate was higher in females (56.5%) than male (43.5%) and was highest in individuals of 20-30 years of age (57.65%). The MIC of the oxacillin sodium salt ranged from 4-32 μg/ml. The multi-antibiotic resistance indices show that 53.4% had Multiple Antibiotic Resistance Indexing (MARI) higher than 0.2. Penicillin binding protein 2a was detected in 8.4% of MRSA isolates, all from nasal carriage while mecA gene was detected in 5 of isolates.

conclusionThis study showed a very high prevalence of MRSA carriage among studied subjects.

Indexed as

AntibiogramCommunity-associated methicillin resistant Staphylococcus aureus (CA-MRSA)Mec A geneNigeriaPBP2aPrevalence

Identifiers

PMID28217194
PMCPMC5278563
OpenAlexW2584139028

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.